Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01285492 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: QVA149
DRUG: Tiotropium

Sponsor

Novartis Pharmaceuticals